The Borregaard Clinical Ascending Investigator grant from Novo Nordisk Foundation funds Danish clinicians for innovative five-year research projects in clinical and translational medicine.
Funder: Novo Nordisk Foundation
Due Dates: January 20, 2027
Funding Amounts: Up to DKK 11,000,000 per grant for 5 years; up to 4 grants awarded; total call budget DKK 44 million.
Summary: Supports Danish clinicians and research leaders for innovative clinical and translational medicine projects to advance patient and human health.
Key Information: Applicants must be mid-career, clinically active MDs in Denmark; professors are not eligible.
This grant supports mid-career Danish clinicians and research leaders undertaking ambitious 5-year projects in clinical and translational medicine. The aim is to enable outstanding clinical researchers to dedicate half their time to research while maintaining clinical responsibilities, thus strengthening the integration of research and patient care in Denmark. Projects should address medical research relevant to patients and human health, spanning a broad range of topics such as disease mechanisms, diagnostics, treatment methods, epidemiology, public health, and clinical trials.